Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs - Wikidata - wikimedia - TriplyDB

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

http://www.wikidata.org/entity/Q33801128

about

mMass as a software tool for the annotation of cyclic peptide tandem mass spectra Selectivity and potency of microcystin congeners against OATP1B1 and OATP1B3 expressing cancer cells Bioprospecting marine plankton Biologically active secondary metabolites from marine cyanobacteria Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets.High levels of structural diversity observed in microcystins from Microcystis CAWBG11 and characterization of six new microcystin congeners.Identification of inhibitors of biological interactions involving intrinsically disordered proteins.Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.Hepatotoxic seafood poisoning (HSP) due to microcystins: a threat from the ocean?MTI-101 (cyclized HYD1) binds a CD44 containing complex and induces necrotic cell death in multiple myeloma The chemistry and biology of organic guanidine derivatives.Cyanobacteria: potential candidates for drug discovery.Organic anion-transporting polypeptides: a novel approach for cancer therapy.Cyanobacteria and cyanotoxins: from impacts on aquatic ecosystems and human health to anticarcinogenic effects.Anticancer compounds from cyanobacterium Lyngbya species: a review.Cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells.Synthesis of Highly Selective Submicromolar Microcystin-Based Inhibitors of Protein Phosphatase (PP)2A over PP1.Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides.Baltic cyanobacteria – a source of biologically active compounds Theoretical Study on Cyclopeptides as the Nanocarriers for Li+, Na+, K+and F−, Cl−, Br−

P2860

Q28483744-952222A3-23FE-4C3D-8223-5549F7AA8A74 Q28540711-561F2B75-F01C-4710-8364-0A466FAAB98C Q28661272-9086AB7C-1B68-44D6-9CF2-8BB28E4289EE Q34554921-688367A2-D53F-4CB2-B06E-E5ABA076489C Q34883276-B806D7C3-C38A-4CAE-B43B-2DD5AF48CEE0 Q35428374-C438AFE5-166F-4446-BDDC-80A67113832E Q35585498-D6E38F57-5C24-46EA-A87C-4355BCA98F5D Q36197335-82ADCB30-7040-40C0-8BEB-F8B2F63903DD Q36616448-81B2813A-4EA7-4C40-8AA3-65BAD9F69B75 Q37155577-D8BF3D59-55D6-483B-910E-6CDEC68D3C38 Q37385307-D3F153DD-B9DD-4ED7-B1A8-F92D9FA1239E Q38044691-10EC4A93-CEA7-4C54-9E7E-BD05724AAD9E Q38093448-87AB6203-5732-48EC-BF35-9920B658B4F5 Q38132411-FE6DEEFC-33F1-4639-A141-93849A23FAD6 Q38155037-30E57E3B-EDC9-4442-87E1-E8024ADC5E76 Q38508840-108EACA0-2531-40DC-9FC5-D1294AC09A60 Q39007306-ECE4827D-89E8-4B18-A4DC-8A29028EE2FA Q42366758-9B4F541A-605F-4596-AE23-B28A551E9428 Q52646693-C7D44FAD-3790-4589-81C7-F241660A3D7D Q57265882-AF8A8939-95E9-4EED-BAF0-697741213CD0 Q59113284-A07712B1-33BF-4AF6-9F36-6FD1C066F433

P2860

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

http://www.wikidata.org/entity/Q33801128

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

@ast

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

@en

type

label

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

@ast

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

@en

prefLabel

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

@ast

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

@en

P1433

Q33801128-1DC5AB6F-7B19-4312-A3D2-21DC5ED6BDDB

P1476

Q33801128-9CEC6879-6E73-497D-B7B1-53E158EF635E

P2093

Q33801128-1F19DAC1-34E0-4445-9C73-5B22FD2F2E74

Q33801128-79651366-8F59-49AD-A920-AE01748A4732

Q33801128-9925B6B0-6A34-4E42-81F2-39202C5A3C69

Q33801128-99281A4E-F386-4126-AF2D-A3AD8A1FBCEA

Q33801128-EB295AD7-8C88-467C-A177-F94A33AF5A44

Q33801128-F752F10A-A360-4FB6-8ABD-8A36B1406A69

P275

Q33801128-C90831A7-60F1-43E8-8B0A-39AFF96E30A9

P2860

Q33801128-00E2A0A7-E11E-439C-8272-9F4CADFC2515

Q33801128-02246786-EAFC-4CF7-B0F9-2577EA394AF1

Q33801128-0376E1A8-062C-483C-849E-14C4066180FE

Q33801128-07AC68D6-6258-4FBE-90BD-C381830EB313

Q33801128-08C1E032-A311-40AA-A64E-6572CE88E41C

Q33801128-0C128C3C-1BCB-4790-BC9B-7A5EB4D3D2B4

Q33801128-0D4C168E-50FC-4B61-A006-B871CC474D01

Q33801128-0D8B7AC1-8166-4E46-9E09-7FE23D5B45C5

Q33801128-0FAF9993-E660-4C2B-83D4-403A10FD09B9

Q33801128-11A49EE0-6201-46B9-96C4-64288578F989

P304

Q33801128-730D6194-E3A6-48FC-8EE9-7A4B48135E72

P31

Q33801128-37DECA93-5060-4B1B-92CF-C05CAC313103

Q33801128-F796DA4C-F155-406A-B1C8-AAD1E7B3C086

P356

Q33801128-181EBDA1-C52E-44EA-BF7A-82525250C7AF

P433

Q33801128-92F39817-B9C8-4FF8-A3F6-5BEA6A56732F

P478

Q33801128-3E2CE9BF-0765-425D-8127-FCEB5A78C9F8

P577

Q33801128-55833715-858F-4179-9451-D1F0410959FC

P5875

Q33801128-6CF14CE8-794F-4E0C-8CEE-52BAF4991A34

P698

Q33801128-565D6B3F-3949-469C-AC8F-FD9B1EFBE90F

P921

Q33801128-01A62E15-4283-473D-9D35-238807CCF490

Q33801128-CA57D21A-3D93-44A8-8160-797EBB449F11

Q33801128-E175E8BB-8511-480A-87BA-9FDD36C59658

P932

Q33801128-4702EFCD-2635-479B-B510-AEF94E074321

P356

P1433

P1476

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs

@en

P2093

Andreas G Tzakos

http://www.w3.org/2001/XMLSchema#string

Demosthenes Fokas

http://www.w3.org/2001/XMLSchema#string

Evangelos Briasoulis

http://www.w3.org/2001/XMLSchema#string

Ioannis Sainis

http://www.w3.org/2001/XMLSchema#string

Katerina Vareli

http://www.w3.org/2001/XMLSchema#string

Valentinos Kounnis

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins

PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum

Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling

Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney

Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins

Crystal structure of the termination module of a nonribosomal peptide synthetase

Dynamic thiolation–thioesterase structure of a non-ribosomal peptide synthetase

Structural basis for the selectivity of the external thioesterase of the surfactin synthetase

Crystal structure of DltA. Implications for the reaction mechanism of non-ribosomal peptide synthetase adenylation domains

Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1

P304

629-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MD8030629

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43248246

http://www.w3.org/2001/XMLSchema#string

P698

20411119

http://www.w3.org/2001/XMLSchema#string

P921

P932

2857373

http://www.w3.org/2001/XMLSchema#string